Dronabinol 2.5 MG Oral Capsule [Marinol] — RxCUI 205641
RxNorm drug concept · Semantic branded drug
RxCUI 205641
Semantic branded drug · SBD
● Current RxNorm concept 6 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI205641
Official nameDronabinol 2.5 MG Oral Capsule [Marinol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMarinol 2.5 MG Oral Capsule
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dronabinol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dronabinol is specifically approved for situations where standard anti-nausea medications haven't worked well enough. It works differently from typical anti-nausea drugs — it acts...
- Why did my doctor prescribe this instead of a regular anti-nausea pill?
- Yes, that's a known and expected effect — the clinical trials even tracked it. You might feel euphoric, giggly, or have a heightened sense of awareness, especially early on. The go...
- Will this make me feel "high"? Is that normal?
🕸️ Concept Web — How Dronabinol 2.5 MG Oral Capsule [Marinol] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dronabinol 2.5 MG Oral Capsule [Marinol]
RxCUI 205641 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dronabinol
10402IN
-
Dronabinol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Marinol
224925BN
-
Marinol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dronabinol Oral Capsule
371971SCDF -
Dronabinol Oral Product
1164871SCDG -
Dronabinol Pill
1164872SCDG -
Dronabinol Oral Capsule [Marinol]
366777SBDF -
Marinol Oral Product
1181015SBDG -
Marinol Pill
1181016SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Dronabinol Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dronabinol 2.5 MG Oral Capsule
197635SCD -
Dronabinol 2.5 MG
315844SCDC -
Dronabinol 2.5 MG [Marinol]
566533SBDC
-
Dronabinol 2.5 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dronabinol 2.5 MG Oral Capsule
SCD · 197635 -
Dronabinol 2.5 MG
SCDC · 315844 -
Dronabinol Oral Capsule
SCDF · 371971 -
Dronabinol Oral Product
SCDG · 1164871 -
Dronabinol Pill
SCDG · 1164872
Brand-Name Concepts
-
Dronabinol 2.5 MG [Marinol]
SBDC · 566533 -
Dronabinol Oral Capsule [Marinol]
SBDF · 366777 -
Marinol Oral Product
SBDG · 1181015 -
Marinol Pill
SBDG · 1181016 -
Marinol
BN · 224925
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
6 package NDCs map to RxCUI 205641 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 53097-0568-60 | 1 BOTTLE in 1 CARTON (53097-568-60) / 60 CAPSULE in 1 BOTTL... | Marinol | ThePharmaNetwork, LLC | 2017-05-10 |
| 53097-0569-60 | 1 BOTTLE in 1 CARTON (53097-569-60) / 60 CAPSULE in 1 BOTTL... | Marinol | ThePharmaNetwork, LLC | 2017-05-10 |
| 53097-0570-60 | 1 BOTTLE in 1 CARTON (53097-570-60) / 60 CAPSULE in 1 BOTTL... | Marinol | ThePharmaNetwork, LLC | 2017-05-10 |
| 53097-0571-60 | 60 CAPSULE in 1 BOTTLE (53097-571-60) | MARINOL | ThePharmaNetwork, LLC | 2021-03-03 |
| 53097-0572-60 | 60 CAPSULE in 1 BOTTLE (53097-572-60) | MARINOL | ThePharmaNetwork, LLC | 2021-03-03 |
| 53097-0573-60 | 60 CAPSULE in 1 BOTTLE (53097-573-60) | MARINOL | ThePharmaNetwork, LLC | 2021-03-03 |
Observed labelers:
ThePharmaNetwork, LLC (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| Q0167 | Dronabinol 2.5mg oral | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.